These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17141847)

  • 1. Delayed L-DOPA-induced hyperalgesia.
    Shimizu T; Iwata S; Miyata A; Fukuda T; Nomoto M
    Pharmacol Biochem Behav; 2006 Nov; 85(3):643-7. PubMed ID: 17141847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive mechanism of L-DOPA.
    Shimizu T; Iwata S; Morioka H; Masuyama T; Fukuda T; Nomoto M
    Pain; 2004 Jul; 110(1-2):246-9. PubMed ID: 15275774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses.
    Paalzow GH
    J Pharmacol Exp Ther; 1992 Nov; 263(2):470-9. PubMed ID: 1432683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.
    Taylor JL; Bishop C; Walker PD
    Pharmacol Biochem Behav; 2005 Aug; 81(4):887-93. PubMed ID: 16023708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
    Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
    Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopaminergic system plays a role in the effect of lithium on inhibitory avoidance memory in mice.
    Zarrindast MR; Misaghi S; Ahmadi S
    Eur J Pharmacol; 2008 Aug; 590(1-3):198-203. PubMed ID: 18606403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
    Matsushita N; Misu Y; Goshima Y
    Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
    Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F
    Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism.
    Sheng HY; Qu CL; Huo FQ; Du JQ; Tang JS
    Exp Neurol; 2009 Jan; 215(1):128-34. PubMed ID: 18952080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents.
    Zarrindast MR; Asgari-Afshar A; Sahebgharani M
    Behav Pharmacol; 2007 May; 18(3):177-84. PubMed ID: 17426481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of dopamine biosynthesis by l-DOPA in PC12 cells: implications of L-DOPA influx and cyclic AMP.
    Jin CM; Yang YJ; Huang HS; Lim SC; Kai M; Lee MK
    Eur J Pharmacol; 2008 Sep; 591(1-3):88-95. PubMed ID: 18602388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D2-dopamine receptor and alpha2-adrenoreceptor-mediated analgesic response of quercetin.
    Naidu PS; Singh A; Kulkarni SK
    Indian J Exp Biol; 2003 Dec; 41(12):1400-4. PubMed ID: 15320492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor mechanism(s) and antinociception and tolerance induced by swim stress in formalin test.
    Fazli-Tabaei S; Yahyavi SH; Nouri M; Zartab H; Javid G; Loghavi S; Zarrindast MR
    Behav Pharmacol; 2006 Jun; 17(4):341-7. PubMed ID: 16914952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
    Eskow KL; Gupta V; Alam S; Park JY; Bishop C
    Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of renal dopamine synthesis in the diuretic effect of furosemide in normohydrated rats.
    Nowicki S; Levin G; Enero MA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1377-80. PubMed ID: 8450472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological modulation of dopaminergic brain activity and its reflection in spectral frequencies of the rat electropharmacogram.
    Dimpfel W
    Neuropsychobiology; 2008; 58(3-4):178-86. PubMed ID: 19142029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    Antonaccio MJ; Kerwin L
    J Pharmacol Exp Ther; 1976 Feb; 196(2):380-8. PubMed ID: 1255483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Central action of beta-phenylethylamine derivatives (10). Effect of L-Dopa on metaraminol induced motor activity (author's transl)].
    Shoji T; Tadano T; Kisara K
    Nihon Yakurigaku Zasshi; 1977 May; 73(4):371-8. PubMed ID: 908541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.